We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Trimble
TRMB
$11.8B
| $6.2M | 0.02% |
173,698
-9,122
| -5% | -$317K |
|
|
ALDR
377
DELISTED
Alder Biopharmaceuticals
ALDR
| $6.16M | 0.02% |
537,835
+12,707
| +2% | +$235K |
|
378
Caterpillar
CAT
$416B
| $6.09M | 0.02% |
56,725
+3,848
| +7% | +$391K |
|
379
LKQ Corp
LKQ
$6.4B
| $6.09M | 0.02% |
184,836
-49,142
| -21% | -$1.52M |
|
380
Sysco
SYY
$38.8B
| $6.01M | 0.02% |
119,488
+81,130
| +212% | +$4.33M |
|
381
Eli Lilly
LLY
$1.05T
| $6M | 0.02% |
72,869
+1,127
| +2% | +$91.9K |
|
382
Union Pacific
UNP
$184B
| $5.95M | 0.02% |
54,651
-267
| -0.5% | -$29.1K |
|
383
iShares Core MSCI EAFE ETF
IEFA
$185B
| $5.9M | 0.02% |
96,947
+32,474
| +50% | +$1.96M |
|
384
S&P Global
SPGI
$124B
| $5.89M | 0.02% |
40,366
-1,177
| -3% | -$163K |
|
|
P
385
Everpure Inc
P
$25.1B
| $5.88M | 0.02% |
458,753
| – | – |
|
386
Addus HomeCare
ADUS
$2.09B
| $5.84M | 0.02% |
157,123
-57,922
| -27% | -$2.08M |
|
387
Morgan Stanley
MS
$340B
| $5.81M | 0.02% |
130,390
+19,236
| +17% | +$829K |
|
388
NextEra Energy
NEE
$188B
| $5.81M | 0.02% |
165,768
-1,128
| -0.7% | -$38.6K |
|
389
Enterprise Products Partners
EPD
$84.2B
| $5.79M | 0.02% |
213,989
+33,307
| +18% | +$902K |
|
390
iShares Residential and Multisector Real Estate ETF
REZ
$905M
| $5.77M | 0.02% |
88,741
-12,494
| -12% | -$810K |
|
|
AGN
391
DELISTED
Allergan plc
AGN
| $5.77M | 0.02% |
23,727
-316
| -1% | -$74.3K |
|
392
CSX Corp
CSX
$97.7B
| $5.64M | 0.02% |
310,302
+186
| +0.1% | +$3.19K |
|
|
HOLX
393
DELISTED
Hologic
HOLX
| $5.62M | 0.02% |
123,858
+8,038
| +7% | +$355K |
|
394
iShares MSCI Emerging Markets ETF
EEM
$28.7B
| $5.41M | 0.02% |
130,777
+6,358
| +5% | +$259K |
|
395
Brown-Forman Class A
BF.A
$12.2B
| $5.35M | 0.02% |
135,610
| – | – |
|
396
iShares Russell 1000 ETF
IWB
$47.8B
| $5.34M | 0.02% |
39,486
+296
| +0.8% | +$39.5K |
|
397
iShare MSCI Eurozone ETF
EZU
$9.38B
| $5.34M | 0.02% |
132,408
+95,438
| +258% | +$3.81M |
|
398
PACCAR
PCAR
$69.8B
| $5.32M | 0.02% |
120,734
-4,090
| -3% | -$177K |
|
399
Cedar Fair
FUN
$1.69B
| $5.32M | 0.02% |
73,725
-833
| -1% | -$58.6K |
|
|
VAR
400
DELISTED
Varian Medical Systems, Inc.
VAR
| $5.31M | 0.02% |
51,494
-545
| -1% | -$52.5K |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.